Latest Reports
Anovulation Market
Anovulation Market, By Treatment Type (Medication, Assisted Reproductive Technology (ART), Surgical Intervention, Others), By Disease Indication (Polycystic Ovary Syndrome (PCOS), Hypothalamic Amenorrhea, Premature Ovarian Failure, Hyperprolactinemia, Thyroid Disorders, Others), By Route of Administration (Oral, Injectable, Implants, Others), By End-user (Hospitals, Fertility Clinics, Academic and Research Institutes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Age Group (Below 25 Years, 25-35 Years, 35-45 Years, above 45 Years), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., Inc., Ferring Pharmaceuticals, Bayer AG, Novartis AG, Pfizer Inc., Sanofi
Erectile Dysfunction Market
Erectile Dysfunction Market, By Product Type (Oral Medications, Injectable Medications, Penile Implants, Vacuum Devices, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Mail-order, Others), By Age Group (Below 30 Years, 30-50 Years, 51-70 Years, Above 70 Years), By Disease Indication (Diabetes, Cardiovascular Diseases, Neurological Disorders, Prostate Cancer, Others), By End User (Hospitals, Clinics, Home Care Settings, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Pfizer Inc., Eli Lilly and Company, Bayer AG, Allergan plc, Mylan N.V., Sanofi S.A.
Charcot-Marie-Tooth Disease Market
Charcot-Marie-Tooth Disease Market, By Type of Charcot-Marie-Tooth Disease (CMT1 (Demyelinating CMT), CMT2 (Axonal CMT), CMT3 (Dejerine-Sottas Disease), CMT4 (Demyelinating CMT with other inherited disorders), Others), By Mutation Type (PMP22 Duplication, MFN2 Mutation, GJB1 Mutation, MPZ Mutation, SH3TC2 Mutation, GDAP1 Mutation, Others), By Treatment Type (Gene Therapy, Symptomatic Treatment, Physiotherapy, Assistive Devices, Others), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Ionis Pharmaceuticals, Biogen, Pharnext, Acceleron Pharma, Alnylam Pharmaceuticals, Sanofi
Cerebrotendinous Xanthomatosis Market
Cerebrotendinous Xanthomatosis Market, By Product Type (Chenodeoxycholic Acid (CDCA) Formulations, Gene Therapy Products, Enzyme Replacement Therapies, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End User (Hospitals, Specialty Clinics, Research Institutes, Others), By Treatment Type (Monotherapy, Combination Therapy, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Leadiant Biosciences, Inc., Travere Therapeutics, Inc., Sanofi, Recordati Rare Diseases, HRA Pharma
Autism Spectrum Disorder Market
Autism Spectrum Disorder Market, By Disorder Type (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS), Childhood Disintegrative Disorder, Rett Syndrome), By Treatment Type (Behavioral Therapy, Speech and Language Therapy, Occupational Therapy, Pharmacological Treatment, Complementary and Alternative Therapies, Others), By End-User (Hospitals and Clinics, Rehabilitation Centers, Therapeutic Centers, Others), By Age Group (Children (0-12 years), Adolescents (13-17 years), Adults (18 years and above)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Product Type (Drugs, Devices, Services), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Roche, Novartis, Pfizer, Johnson & Johnson, GlaxoSmithKline, Merck & Co., Sanofi
Argininosuccinic Aciduria Market
Argininosuccinic Aciduria Market, By Treatment Type (Dietary Management, Enzyme Replacement Therapy, Gene Therapy, Liver Transplantation, Others), By Route of Administration (Oral, Intravenous, Others), By Age Group (Neonates, Infants, Children, Adults), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Clinics, Homecare Settings, Others), By Dosage Form (Tablets, Capsules, Injections, Oral Solutions, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Horizon Therapeutics, Ultragenyx Pharmaceutical, Aeglea BioTherapeutics, Homology Medicines
Huntington's Disease Treatment Market
Huntington's Disease Treatment Market, By Product Type (Gene Therapies, Antisense Oligonucleotides, Small Molecule Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End User (Hospitals, Specialty Clinics, Home Healthcare, Others), By Mechanism of Action (Huntingtin Lowering Therapies, Neuroprotective Therapies, Symptomatic Therapies, Others), By Stage of Disease (Early-Stage, Mid-Stage, Late-Stage), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Roche, Ionis Pharmaceuticals, Wave Life Sciences, UniQure, Sangamo Therapeutics, Pfizer
Stem Cell Therapy Market
Stem Cell Therapy Market, By Source (Embryonic Stem Cells Induced Pluripotent Stem Cells Adult Stem Cells Umbilical Cord Stem Cells Others), By Type (Allogeneic Stem Cell Therapy Autologous Stem Cell Therapy Syngeneic Stem Cell Therapy), By Application (Musculoskeletal Disorders Cardiovascular Diseases Neurological Disorders Autoimmune Diseases Oncology Wounds and Injuries Others), By Technology (Cell Acquisition Cell Production Cryopreservation Expansion and Sub-Culture Others), By End User (Hospitals and Clinics Academic and Research Institutes Biotechnology and Pharmaceutical Companies Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Mesoblast Limited, Osiris Therapeutics, Inc, MEDIPOST Co. Ltd, Holostem Terapie Avanzate S.r.l.
CRISPR Gene Editing Market
CRISPR Gene Editing Market, By Product Type (Vector-based CRISPR products, DNA-free CRISPR products, Gene drive CRISPR products, Others), By Application (Biomedical applications, Agricultural applications, Industrial applications, Basic research, Others), By End-User (Pharmaceutical and biopharmaceutical companies, Academic and government research institutes, Contract research organizations, Biotechnology companies, Others), By Delivery Mode (Ex vivo, In vivo, Others), By Technology (CRISPR/Cas9, CRISPR/Cpf1 (Cas12a), Other CRISPR systems), By Service Type (Gene engineering design, Genomic screening, Other services), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Caribou Biosciences
Insomnia Market
Global Insomnia Market, By Product Type (Prescription sleep medications, Over-the-counter sleep aids, Medical devices), By Insomnia Type (Chronic insomnia, Acute insomnia, Comorbid insomnia, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Others), By Treatment (Pharmacological treatments, Non-pharmacological treatments (e.g., CBT, relaxation techniques), Others), By End User (Hospitals, Sleep centers, Clinics, Home care settings, Others), By Cause (Medical conditions (e.g., chronic pain, cancer), Psychiatric disorders (e.g., anxiety, depression), Substance abuse, Lifestyle factors (e.g., stress, jet lag), Hormonal imbalances, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Sanofi, Merck & Co., Pfizer Inc., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd.